Literature DB >> 21813648

Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.

Mónica Alvarez-Fernández1, Vincentius A Halim, Melinda Aprelia, Jamila Laoukili, Shabaz Mohammed, René H Medema.   

Abstract

The forkhead transcription factor FoxM1 controls expression of a large number of genes that are specifically expressed during the G(2) phase of the cell cycle. Throughout most of the cell cycle, FoxM1 activity is restrained by an autoinhibitory mechanism, involving a repressor domain present in the N-terminal part of the protein. Activation of FoxM1 in G(2) is achieved by Cyclin A/Cyclin-dependent kinase (Cdk)-mediated phosphorylation, which alleviates autoinhibition by the N-terminal repressor domain. Here, we show that FoxM1 interacts with B55α, a regulatory subunit of protein phosphatase 2A (PP2A). B55α binds the catalytic subunit of PP2A, and this promotes dephosphorylation and inactivation of FoxM1. Indeed, we find that overexpression of B55α results in decreased FoxM1 activity. Inversely, depletion of B55α results in premature activation of FoxM1. The activation of FoxM1 that is observed upon depletion of B55α is fully dependent on Cyclin A/Cdk-mediated phosphorylation of FoxM1. Taken together, these data demonstrate that B55α acts to antagonize Cyclin A/Cdk-dependent activation of FoxM1, to ensure that FoxM1 activity is restricted to the G(2) phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813648      PMCID: PMC3190881          DOI: 10.1074/jbc.M111.253724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Transcriptional regulatory networks and the yeast cell cycle.

Authors:  Bruce Futcher
Journal:  Curr Opin Cell Biol       Date:  2002-12       Impact factor: 8.382

2.  Identification of specific PP2A complexes involved in human cell transformation.

Authors:  Wen Chen; Richard Possemato; K Thirza Campbell; Courtney A Plattner; David C Pallas; William C Hahn
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

3.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

4.  An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.

Authors:  H J Park; Z Wang; R H Costa; A Tyner; L F Lau; P Raychaudhuri
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

5.  The winged-helix transcription factor Trident is expressed in cycling cells.

Authors:  W Korver; J Roose; H Clevers
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

Review 6.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

Review 7.  PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail).

Authors:  Veerle Janssens; Sari Longin; Jozef Goris
Journal:  Trends Biochem Sci       Date:  2008-03       Impact factor: 13.807

8.  The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.

Authors:  M K Saville; R J Watson
Journal:  Oncogene       Date:  1998-11-26       Impact factor: 9.867

9.  Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster.

Authors:  Martijn W H Pinkse; Shabaz Mohammed; Joost W Gouw; Bas van Breukelen; Harmjan R Vos; Albert J R Heck
Journal:  J Proteome Res       Date:  2007-11-23       Impact factor: 4.466

10.  Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions.

Authors:  Hee-Don Chae; Jeanho Yun; Yung-Jue Bang; Deug Y Shin
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

View more
  18 in total

1.  miR-660 promotes liver cancer cell proliferation by targeting PPP2R2A.

Authors:  Yaozhen Pan; Lei Zhan; Ling Chen; Liwen Chen; Chengyi Sun
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

2.  The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Rodrigo Jacamo; Jared K Burks; Zhihong Zeng; Seshagiri R Duvvuri; Liran Zhou; Yihua Qiu; Kevin R Coombes; Nianxiang Zhang; Suk Y Yoo; Rongqing Pan; Numsen Hail; Marina Konopleva; George Calin; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta       Date:  2014-05-21

3.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

Authors:  Sining Shen; Han Yue; Yin Li; Jianjun Qin; Ke Li; Ying Liu; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2014-01

4.  The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress.

Authors:  Ling Yan; Shuangli Guo; Marie Brault; Jamie Harmon; R Paul Robertson; Rizwan Hamid; Roland Stein; Elizabeth Yang
Journal:  Biochem J       Date:  2012-06-01       Impact factor: 3.857

Review 5.  Roles of FoxM1 in cell regulation and breast cancer targeting therapy.

Authors:  Xin Song; Samuel Selorm Fiati Kenston; Jinshun Zhao; Danting Yang; Yuanliang Gu
Journal:  Med Oncol       Date:  2017-02-08       Impact factor: 3.064

6.  The B55α regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes.

Authors:  Victoria Kolupaeva; Lea Daempfling; Claudio Basilico
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

Review 7.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

Review 8.  Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Authors:  Godfrey Grech; Shawn Baldacchino; Christian Saliba; Maria Pia Grixti; Robert Gauci; Vanessa Petroni; Anthony G Fenech; Christian Scerri
Journal:  Tumour Biol       Date:  2016-07-21

Review 9.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

10.  Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.

Authors:  Deborah A Sanders; Caryn S Ross-Innes; Dario Beraldi; Jason S Carroll; Shankar Balasubramanian
Journal:  Genome Biol       Date:  2013-01-24       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.